Paratek

There’s No Escaping Paratek Pharmaceuticals, Inc.’s (NASDAQ:PRTK) Muted Revenues Despite A 77{1668a97e7bfe6d80c144078b89af180f360665b4ea188e6054b2f93f7302966b} Share Price Rise

Pharmacy Industry

What Does Paratek Pharmaceuticals’ P/S Imply For Shareholders?

By Rachel Pence 2 years ago

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) shareholders would be thrilled to see that the share price tag